Trial intelligence / Profile preview

MEBO Wound Ointment in diabetic foot ulcers

NCT01070433Phase 2Completed

Sponsor
Skingenix, Inc.
Start
Sep 2012
Primary completion
Sep 2013
Modality
Botanical drug
Countries
1
01

Overview

A Phase 2 trial of MEBO Moist Burn Ointment in diabetic foot ulcer (DFU), sponsored by Skingenix, Inc.. Started Sep 2012; status: completed.

02

Drugs

MEBO Moist Burn Ointment
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT01070433.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01070433.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call